CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 100 enrolled
Drug / intervention
Implantation of Ahmed glaucoma tube shunt, and Trabeculectomy with MMCprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01633775
NCT01633775N/ACompleted
CompareCT.gov

Re-Trabeculectomy Versus Ahmed Glaucoma Valve Implantation in Secondary Surgical Management of Patients With Refractory Primary Open Angle Glaucoma: a Three-year Comparative Study

Vanak Eye Surgery Center·observational·Posted Jul 4, 2012·Updated Jul 4, 2012

In Brief

An observational study evaluating Implantation of Ahmed glaucoma tube shunt, and Trabeculectomy with MMC for Refractory Primary Open Angle Glaucoma. Completed, enrolled 100 participants across 3 sites.

Detailed Summary

The purpose of this study is to compare three-year outcomes of re-trabeculectomy with those of Ahmed glaucoma valve implantation in secondary surgical management of patients with primary open angle glaucoma (POAG) and a history of previous failed trabeculectomy.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsRefractory Primary Open Angle Glaucoma
CountriesIran
Collaborators--

Timeline

N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJul 4, 2012
Enrollment StartDec 1, 2007
Primary CompletionJan 1, 2012
TodayJul 2, 2026
Enrollment to primary: 4.1 yearsPosted 14.0 years ago

Interventions

Implantation of Ahmed glaucoma tube shunt, and Trabeculectomy with MMCprocedure

In the Ahmed implant group, the tube shunts used were the valved 184-mm2 surface area (Model FP7; New World Medical, Inc, Rancho Cucamonga, California, USA). In the Trabeculectomy group, a routine trabeculectomy surgery was performed.